144 related articles for article (PubMed ID: 10454752)
1. Genetic susceptibility to HPV infection and cervical cancer.
Maciag PC; Villa LL
Braz J Med Biol Res; 1999 Jul; 32(7):915-22. PubMed ID: 10454752
[TBL] [Abstract][Full Text] [Related]
2. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
[TBL] [Abstract][Full Text] [Related]
3. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India.
Nagpal JK; Patnaik S; Das BR
Int J Cancer; 2002 Feb; 97(5):649-53. PubMed ID: 11807792
[TBL] [Abstract][Full Text] [Related]
5. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value.
Cho NH; Lim SY; Kim YT; Kim D; Kim YS; Kim JW
Gynecol Oncol; 2003 Jul; 90(1):15-22. PubMed ID: 12821336
[TBL] [Abstract][Full Text] [Related]
6. [Expression of VEGF, KDR, p53, E6 HPV16 and HPV18 in vulvar and cervix cancer].
Michalski B; Mazurek U; Olejek A; Kuśmierz D; Poreba R; Witek A; Wilczok T
Wiad Lek; 2000; 53(5-6):240-6. PubMed ID: 10983377
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India.
Pillai MR; Sreevidya S; Pollock BH; Jayaprakash PG; Herman B
J Cancer Res Clin Oncol; 2002 Nov; 128(11):627-31. PubMed ID: 12458344
[TBL] [Abstract][Full Text] [Related]
8. P53 codon 72 polymorphism as a risk factor in the development of HPV-associated non-melanoma skin cancers in immunocompetent hosts.
Dokianakis DN; Koumantaki E; Billiri K; Spandidos DA
Int J Mol Med; 2000 Apr; 5(4):405-9. PubMed ID: 10719058
[TBL] [Abstract][Full Text] [Related]
9. No evidence of p53 allele-specific predisposition in human papillomavirus-associated cervical cancer.
Klaes R; Ridder R; Schaefer U; Benner A; von Knebel Doeberitz M
J Mol Med (Berl); 1999 Feb; 77(2):299-302. PubMed ID: 10023783
[TBL] [Abstract][Full Text] [Related]
10. P53 codon 72 polymorphism and human papillomavirus type in relation to cervical cancer in South African women.
Pegoraro RJ; Rom L; Lanning PA; Moodley M; Naiker S; Moodley J
Int J Gynecol Cancer; 2002; 12(4):383-8. PubMed ID: 12144687
[TBL] [Abstract][Full Text] [Related]
11. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
[TBL] [Abstract][Full Text] [Related]
12. p53 alterations and HPV infections are common in oral SCC: p53 gene mutations correlate with the absence of HPV 16-E6 DNA.
Penhallow J; Steingrimsdottir H; Elamin F; Warnakulasuriya S; Farzaneh F; Johnson N; Tavassoli M
Int J Oncol; 1998 Jan; 12(1):59-68. PubMed ID: 9454887
[TBL] [Abstract][Full Text] [Related]
13. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva.
Milde-Langosch K; Albrecht K; Joram S; Schlechte H; Giessing M; Löning T
Int J Cancer; 1995 Nov; 63(5):639-45. PubMed ID: 7591279
[TBL] [Abstract][Full Text] [Related]
14. P53 codon 72 polymorphism and susceptibility to development of human papilloma virus-associated cervical cancer in Indian women.
Nagpal JK; Sahni S; Das BR
Eur J Clin Invest; 2002 Dec; 32(12):943-8. PubMed ID: 12534455
[TBL] [Abstract][Full Text] [Related]
15. Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers.
Szarka K; Veress G; Juhász A; Kónya J; Sápy T; Soós G; Hernádi Z; Gergely L
Anticancer Res; 2000; 20(3B):2161-7. PubMed ID: 10928171
[TBL] [Abstract][Full Text] [Related]
16. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
[TBL] [Abstract][Full Text] [Related]
17. High-risk human papillomavirus infection and E6 protein expression in lesions of the uterine cervix.
Pillai MR; Lakshmi S; Sreekala S; Devi TG; Jayaprakash PG; Rajalakshmi TN; Devi CG; Nair MK; Nair MB
Pathobiology; 1998; 66(5):240-6. PubMed ID: 9732239
[TBL] [Abstract][Full Text] [Related]
18. p53 polymorphism and human papillomavirus infection in Hong Kong women with cervical cancer.
Wong YF; Chung TK; Cheung TH; Nobori T; Hampton GM; Wang VW; Li YF; Chang AM
Gynecol Obstet Invest; 2000; 50(1):60-3. PubMed ID: 10895031
[TBL] [Abstract][Full Text] [Related]
19. The role of p53 inactivation in human cervical cell carcinoma development.
Miwa K; Miyamoto S; Kato H; Imamura T; Nishida M; Yoshikawa Y; Nagata Y; Wake N
Br J Cancer; 1995 Feb; 71(2):219-26. PubMed ID: 7841033
[TBL] [Abstract][Full Text] [Related]
20. Mutations of p53 and human papillomavirus infection in cervical carcinoma.
Paquette RL; Lee YY; Wilczynski SP; Karmakar A; Kizaki M; Miller CW; Koeffler HP
Cancer; 1993 Aug; 72(4):1272-80. PubMed ID: 8393371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
